Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
1,519
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Case Report

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

YunYi Dua Department of Oncology, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
,
XiaoLing Zhanga Department of Oncology, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
,
Ying Zhanga Department of Oncology, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China;b Department of Respiration, Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
,
WeiLing Lia Department of Oncology, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China;b Department of Respiration, Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
,
WenQing Huc Department of Gastrointestinal Surgery, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
,
Liang Zongc Department of Gastrointestinal Surgery, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, ChinaView further author information
&
Jun Zhaoa Department of Oncology, Changzhi people’s Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2121122 | Received 16 Jul 2022, Accepted 23 Aug 2022, Published online: 26 Sep 2022

References

  • Wang J, Pettaway CA, Pagliaro LC. Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes. Urology. 2015;85(5):1–4. doi:10.1016/j.urology.2014.12.049.
  • Subbiah V, Solit DB, Chan TA, Kurzrock R. The FDA approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (TMB) ≥10: a decision centered on empowering patients and their physicians. Ann Oncol. 2020;31(9):1115–18. doi:10.1016/j.annonc.2020.07.002.
  • Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–20. doi:10.1056/NEJMoa1500596.
  • Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–13. doi:10.1126/science.aan6733.
  • Loupakis F, Maddalena G, Depetris I, Murgioni S, Bergamo F, Dei Tos AP, Rugge M, Munari G, Nguyen A, Szeto C, et al. Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status. J Immunother Cancer. 2019;7(1):297. doi:10.1186/s40425-019-0788-5.
  • Udager AM, Liu TY, Skala SL, Magers MJ, McDaniel AS, Spratt DE, Feng FY, Siddiqui J, Cao X, Fields KL, et al. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol. 2016;27(9):1706–12. doi:10.1093/annonc/mdw216.
  • Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O. PD-L1 expression in men with penile cancer and its association with clinical outcomes. Eur Urol Oncol. 2019;2(2):214–21. doi:10.1016/j.euo.2018.07.010.
  • Hahn AW, Chahoud J, Campbell MT, Karp DD, Wang J, Stephen B, Tu S-M, Pettaway CA, Naing A. Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial. Invest New Drugs. 2021;39(5):1405–10. doi:10.1007/s10637-021-01100-x.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.